IBM Watson for Oncology is an advanced artificial intelligence system developed by IBM in collaboration with Memorial Sloan Kettering Cancer Center. This technology leverages machine learning and natural language processing to assist oncologists in making evidence-based treatment decisions for cancer patients. It analyzes vast amounts of medical literature, clinical trial data, and cancer treatment guidelines to recommend personalized treatment options.
